Abstract
Summary
Fumonisin B1 is a mycotoxin produced by Fusarium moniliforme that has been shown to potently inhibit sphingosine N-acyltransferase, thereby disrupting the synthesis of sphingolipids, a key component of plasma membranes.
The global market for Fumonisin B1 was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Fumonisin B1 was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fumonisin B1 was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Fumonisin B1 was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Fumonisin B1 include Adooq Bioscience, LKT Laboratories, Abcam, Spectrum Chemical, StressMarq Biosciences, Biosynth Carbosynth, LGC, Cayman Chemical and Santa Cruz Biotechnology, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fumonisin B1, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fumonisin B1 by region & country, by Type, and by Application.
The Fumonisin B1 market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fumonisin B1.
Market Segmentation
By Company
Adooq Bioscience
LKT Laboratories
Abcam
Spectrum Chemical
StressMarq Biosciences
Biosynth Carbosynth
LGC
Cayman Chemical
Santa Cruz Biotechnology
Bio-Techne
Merck
Enzo Biochem
Focus Biomolecules
STEMCELL Technologies
APExBIO Technology
Pharmaffiliates
Cato Research Chemicals
Aladdin
Segment by Type:
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fumonisin B1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Fumonisin B1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Fumonisin B1 in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Fumonisin B1 was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Fumonisin B1 was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fumonisin B1 was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Fumonisin B1 was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Fumonisin B1 include Adooq Bioscience, LKT Laboratories, Abcam, Spectrum Chemical, StressMarq Biosciences, Biosynth Carbosynth, LGC, Cayman Chemical and Santa Cruz Biotechnology, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fumonisin B1, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fumonisin B1 by region & country, by Type, and by Application.
The Fumonisin B1 market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fumonisin B1.
Market Segmentation
By Company
Adooq Bioscience
LKT Laboratories
Abcam
Spectrum Chemical
StressMarq Biosciences
Biosynth Carbosynth
LGC
Cayman Chemical
Santa Cruz Biotechnology
Bio-Techne
Merck
Enzo Biochem
Focus Biomolecules
STEMCELL Technologies
APExBIO Technology
Pharmaffiliates
Cato Research Chemicals
Aladdin
Segment by Type:
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fumonisin B1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Fumonisin B1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Fumonisin B1 in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Fumonisin B1 Product Introduction
1.2 Global Fumonisin B1 Market Size Forecast
1.2.1 Global Fumonisin B1 Sales Value (2019-2030)
1.2.2 Global Fumonisin B1 Sales Volume (2019-2030)
1.2.3 Global Fumonisin B1 Sales Price (2019-2030)
1.3 Fumonisin B1 Market Trends & Drivers
1.3.1 Fumonisin B1 Industry Trends
1.3.2 Fumonisin B1 Market Drivers & Opportunity
1.3.3 Fumonisin B1 Market Challenges
1.3.4 Fumonisin B1 Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Fumonisin B1 Players Revenue Ranking (2023)
2.2 Global Fumonisin B1 Revenue by Company (2019-2024)
2.3 Global Fumonisin B1 Players Sales Volume Ranking (2023)
2.4 Global Fumonisin B1 Sales Volume by Company Players (2019-2024)
2.5 Global Fumonisin B1 Average Price by Company (2019-2024)
2.6 Key Manufacturers Fumonisin B1 Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Fumonisin B1 Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Fumonisin B1
2.9 Fumonisin B1 Market Competitive Analysis
2.9.1 Fumonisin B1 Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Fumonisin B1 Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fumonisin B1 as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Min Purity Less Than 98%
3.1.2 Min Purity 98%-99%
3.1.3 Min Purity More Than 99%
3.2 Global Fumonisin B1 Sales Value by Type
3.2.1 Global Fumonisin B1 Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Fumonisin B1 Sales Value, by Type (2019-2030)
3.2.3 Global Fumonisin B1 Sales Value, by Type (%) (2019-2030)
3.3 Global Fumonisin B1 Sales Volume by Type
3.3.1 Global Fumonisin B1 Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Fumonisin B1 Sales Volume, by Type (2019-2030)
3.3.3 Global Fumonisin B1 Sales Volume, by Type (%) (2019-2030)
3.4 Global Fumonisin B1 Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research
4.1.2 Medical
4.2 Global Fumonisin B1 Sales Value by Application
4.2.1 Global Fumonisin B1 Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Fumonisin B1 Sales Value, by Application (2019-2030)
4.2.3 Global Fumonisin B1 Sales Value, by Application (%) (2019-2030)
4.3 Global Fumonisin B1 Sales Volume by Application
4.3.1 Global Fumonisin B1 Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Fumonisin B1 Sales Volume, by Application (2019-2030)
4.3.3 Global Fumonisin B1 Sales Volume, by Application (%) (2019-2030)
4.4 Global Fumonisin B1 Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Fumonisin B1 Sales Value by Region
5.1.1 Global Fumonisin B1 Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Fumonisin B1 Sales Value by Region (2019-2024)
5.1.3 Global Fumonisin B1 Sales Value by Region (2025-2030)
5.1.4 Global Fumonisin B1 Sales Value by Region (%), (2019-2030)
5.2 Global Fumonisin B1 Sales Volume by Region
5.2.1 Global Fumonisin B1 Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Fumonisin B1 Sales Volume by Region (2019-2024)
5.2.3 Global Fumonisin B1 Sales Volume by Region (2025-2030)
5.2.4 Global Fumonisin B1 Sales Volume by Region (%), (2019-2030)
5.3 Global Fumonisin B1 Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Fumonisin B1 Sales Value, 2019-2030
5.4.2 North America Fumonisin B1 Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Fumonisin B1 Sales Value, 2019-2030
5.5.2 Europe Fumonisin B1 Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Fumonisin B1 Sales Value, 2019-2030
5.6.2 Asia Pacific Fumonisin B1 Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Fumonisin B1 Sales Value, 2019-2030
5.7.2 South America Fumonisin B1 Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Fumonisin B1 Sales Value, 2019-2030
5.8.2 Middle East & Africa Fumonisin B1 Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Fumonisin B1 Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Fumonisin B1 Sales Value
6.2.1 Key Countries/Regions Fumonisin B1 Sales Value, 2019-2030
6.2.2 Key Countries/Regions Fumonisin B1 Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Fumonisin B1 Sales Value, 2019-2030
6.3.2 United States Fumonisin B1 Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Fumonisin B1 Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Fumonisin B1 Sales Value, 2019-2030
6.4.2 Europe Fumonisin B1 Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Fumonisin B1 Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Fumonisin B1 Sales Value, 2019-2030
6.5.2 China Fumonisin B1 Sales Value by Type (%), 2023 VS 2030
6.5.3 China Fumonisin B1 Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Fumonisin B1 Sales Value, 2019-2030
6.6.2 Japan Fumonisin B1 Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Fumonisin B1 Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Fumonisin B1 Sales Value, 2019-2030
6.7.2 South Korea Fumonisin B1 Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Fumonisin B1 Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Fumonisin B1 Sales Value, 2019-2030
6.8.2 Southeast Asia Fumonisin B1 Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Fumonisin B1 Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Fumonisin B1 Sales Value, 2019-2030
6.9.2 India Fumonisin B1 Sales Value by Type (%), 2023 VS 2030
6.9.3 India Fumonisin B1 Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Adooq Bioscience
7.1.1 Adooq Bioscience Company Information
7.1.2 Adooq Bioscience Introduction and Business Overview
7.1.3 Adooq Bioscience Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Adooq Bioscience Fumonisin B1 Product Offerings
7.1.5 Adooq Bioscience Recent Development
7.2 LKT Laboratories
7.2.1 LKT Laboratories Company Information
7.2.2 LKT Laboratories Introduction and Business Overview
7.2.3 LKT Laboratories Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.2.4 LKT Laboratories Fumonisin B1 Product Offerings
7.2.5 LKT Laboratories Recent Development
7.3 Abcam
7.3.1 Abcam Company Information
7.3.2 Abcam Introduction and Business Overview
7.3.3 Abcam Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Abcam Fumonisin B1 Product Offerings
7.3.5 Abcam Recent Development
7.4 Spectrum Chemical
7.4.1 Spectrum Chemical Company Information
7.4.2 Spectrum Chemical Introduction and Business Overview
7.4.3 Spectrum Chemical Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Spectrum Chemical Fumonisin B1 Product Offerings
7.4.5 Spectrum Chemical Recent Development
7.5 StressMarq Biosciences
7.5.1 StressMarq Biosciences Company Information
7.5.2 StressMarq Biosciences Introduction and Business Overview
7.5.3 StressMarq Biosciences Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.5.4 StressMarq Biosciences Fumonisin B1 Product Offerings
7.5.5 StressMarq Biosciences Recent Development
7.6 Biosynth Carbosynth
7.6.1 Biosynth Carbosynth Company Information
7.6.2 Biosynth Carbosynth Introduction and Business Overview
7.6.3 Biosynth Carbosynth Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Biosynth Carbosynth Fumonisin B1 Product Offerings
7.6.5 Biosynth Carbosynth Recent Development
7.7 LGC
7.7.1 LGC Company Information
7.7.2 LGC Introduction and Business Overview
7.7.3 LGC Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.7.4 LGC Fumonisin B1 Product Offerings
7.7.5 LGC Recent Development
7.8 Cayman Chemical
7.8.1 Cayman Chemical Company Information
7.8.2 Cayman Chemical Introduction and Business Overview
7.8.3 Cayman Chemical Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Cayman Chemical Fumonisin B1 Product Offerings
7.8.5 Cayman Chemical Recent Development
7.9 Santa Cruz Biotechnology
7.9.1 Santa Cruz Biotechnology Company Information
7.9.2 Santa Cruz Biotechnology Introduction and Business Overview
7.9.3 Santa Cruz Biotechnology Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Santa Cruz Biotechnology Fumonisin B1 Product Offerings
7.9.5 Santa Cruz Biotechnology Recent Development
7.10 Bio-Techne
7.10.1 Bio-Techne Company Information
7.10.2 Bio-Techne Introduction and Business Overview
7.10.3 Bio-Techne Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Bio-Techne Fumonisin B1 Product Offerings
7.10.5 Bio-Techne Recent Development
7.11 Merck
7.11.1 Merck Company Information
7.11.2 Merck Introduction and Business Overview
7.11.3 Merck Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Merck Fumonisin B1 Product Offerings
7.11.5 Merck Recent Development
7.12 Enzo Biochem
7.12.1 Enzo Biochem Company Information
7.12.2 Enzo Biochem Introduction and Business Overview
7.12.3 Enzo Biochem Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Enzo Biochem Fumonisin B1 Product Offerings
7.12.5 Enzo Biochem Recent Development
7.13 Focus Biomolecules
7.13.1 Focus Biomolecules Company Information
7.13.2 Focus Biomolecules Introduction and Business Overview
7.13.3 Focus Biomolecules Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Focus Biomolecules Fumonisin B1 Product Offerings
7.13.5 Focus Biomolecules Recent Development
7.14 STEMCELL Technologies
7.14.1 STEMCELL Technologies Company Information
7.14.2 STEMCELL Technologies Introduction and Business Overview
7.14.3 STEMCELL Technologies Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.14.4 STEMCELL Technologies Fumonisin B1 Product Offerings
7.14.5 STEMCELL Technologies Recent Development
7.15 APExBIO Technology
7.15.1 APExBIO Technology Company Information
7.15.2 APExBIO Technology Introduction and Business Overview
7.15.3 APExBIO Technology Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.15.4 APExBIO Technology Fumonisin B1 Product Offerings
7.15.5 APExBIO Technology Recent Development
7.16 Pharmaffiliates
7.16.1 Pharmaffiliates Company Information
7.16.2 Pharmaffiliates Introduction and Business Overview
7.16.3 Pharmaffiliates Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Pharmaffiliates Fumonisin B1 Product Offerings
7.16.5 Pharmaffiliates Recent Development
7.17 Cato Research Chemicals
7.17.1 Cato Research Chemicals Company Information
7.17.2 Cato Research Chemicals Introduction and Business Overview
7.17.3 Cato Research Chemicals Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Cato Research Chemicals Fumonisin B1 Product Offerings
7.17.5 Cato Research Chemicals Recent Development
7.18 Aladdin
7.18.1 Aladdin Company Information
7.18.2 Aladdin Introduction and Business Overview
7.18.3 Aladdin Fumonisin B1 Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Aladdin Fumonisin B1 Product Offerings
7.18.5 Aladdin Recent Development
8 Industry Chain Analysis
8.1 Fumonisin B1 Industrial Chain
8.2 Fumonisin B1 Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Fumonisin B1 Sales Model
8.5.2 Sales Channel
8.5.3 Fumonisin B1 Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer